+1 (704) 266-3234

Global And United States Measles Vaccine Market Size, Status And Forecast 2022

Published on: Apr 2014 | From USD $2922 | Published By: QY RESEARCH | Number Of Pages: 119

This report studies the Measles Vaccine on United States and global market, focuses on the top players in US market and also the market status and outlook by type and application.

Geographically, this report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Measles Vaccine in these regions, from 2012 to 2022 (forecast), covering
North America
Europe
Asia-Pacific
South America
Middle East and Africa

The major players in United States Measles Vaccine market include Bavarian Nordic, Emergent Biosolutions, GlaxoSmithKline, Medimmune, Johnson & Johnson, CSL Limited, Merck & Co., Novartis AG, Pfizer, Sanofi

The On the basis of product, the Measles Vaccine market is primarily split into
MMR-II
Proquad

On the basis on the end users/applications, this report covers
Pediatric Vaccines
Adult Vaccines

Table of Contents

2017-2022 Measles Vaccine Report on United States and Global Market, Status and Forecast, by Players, Types and Applications
1 Methodology and Data Source
1.1 Methodology/Research Approach
1.1.1 Research Programs/Design
1.1.2 Market Size Estimation
1.1.3 Market Breakdown and Data Triangulation
1.2 Data Source
2.1.1 Secondary Sources
2.1.2 Primary Sources
1.3 Disclaimer
2 Measles Vaccine Market Overview
2.1 Measles Vaccine Product Overview
2.2 Measles Vaccine Segment by Types (Product Category)
2.2.1 United States Measles Vaccine Sales and Growth (%) Comparison by Types (Product Category) (2012-2022)
2.2.2 United States Measles Vaccine Sales Market Share (%) by Types (Product Category) in 2016
2.2.3 MMR-II
2.2.4 Proquad
2.3 United States Measles Vaccine Segment by Applications
2.3.1 United States Measles Vaccine Sales (K Sets) Comparison by Applications (2012-2022)
2.3.2 Pediatric Vaccines
2.3.3 Adult Vaccines
2.4 Global Measles Vaccine Market Comparison by Regions (2012-2022)
2.4.1 Global Measles Vaccine Market Size and Growth (%) Comparison by Regions (2012-2022)
2.4.2 North America Measles Vaccine Status and Prospect (2012-2022)
2.4.3 Asia-Pacific Measles Vaccine Status and Prospect (2012-2022)
2.4.4 Europe Measles Vaccine Status and Prospect (2012-2022)
2.4.5 South America Measles Vaccine Status and Prospect (2012-2022)
2.4.6 Middle East and Africa Measles Vaccine Status and Prospect (2012-2022)
2.5 Global Measles Vaccine Market Size (2012-2022)
2.5.1 Global Measles Vaccine Revenue (Million USD) Status and Outlook (2012-2022)
2.5.2 Global Measles Vaccine Sales (K Sets) Status and Outlook (2012-2022)
2.6 United States Measles Vaccine Market Size (2012-2022)
2.6.1 United States Measles Vaccine Revenue (Million USD) Status and Outlook (2012-2022)
2.6.2 United States Measles Vaccine Sales (K Sets) Status and Outlook (2012-2022)
3 United States Measles Vaccine Market Competition by Players/Manufacturers
3.1 United States Measles Vaccine Sales (K Sets) and Share by Players (2012-2017)
3.2 United States Measles Vaccine Revenue (Million USD) and Share by Players (2012-2017)
3.3 United States Measles Vaccine Average Price (USD/Set) by Players (2012-2017)
3.4 Players Measles Vaccine Manufacturing Base Distribution, Sales Area, Product Types
3.5 Measles Vaccine Market Competitive Situation and Trends
3.5.1 Measles Vaccine Market Concentration Rate
3.5.2 Measles Vaccine Market Share (%) of Top 3 and Top 5 Players
3.5.3 Mergers & Acquisitions, Expansion
4 Global Measles Vaccine Market Comparison by Regions
4.2 Global Measles Vaccine Sales (K Sets) and Market Share (%) by Regions (2012-2017)
4.3 Global Measles Vaccine Revenue (Million USD) and Market Share (%) by Regions (2012-2017)
4.3 Global Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set) and Gross Margin (%) (2012-2017)
4.5 North America Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set) and Gross Margin (%) (2012-2017)
4.6 Europe Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set) and Gross Margin (%) (2012-2017)
4.7 Asia-Pacific Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set) and Gross Margin (%) (2012-2017)
4.8 South America Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set) and Gross Margin (2012-2017)
4.9 Middle East and Africa Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set) and Gross Margin (%) (2012-2017)
5 United States Measles Vaccine Sales, Revenue, Price Trend by Types
5.1 United States Measles Vaccine Sales (K Sets) and Market Share (%) by Types (2012-2017)
5.2 United States Measles Vaccine Revenue and Market Share (%) by Types (2012-2017)
5.3 United States Measles Vaccine Price (USD/Set) by Type (2012-2017)
5.4 MMR-II
5.4.1 United States MMR-II Sales (K Sets) and Growth Rate (%) (2012-2017)
5.4.2 United States MMR-II Revenue (Million USD) and Growth Rate (%) (2012-2017)
5.5 Proquad
5.5.1 United States Proquad Sales (K Sets) and Growth Rate (%) (2012-2017)
5.5.2 United States Proquad Revenue (Million USD) and Growth Rate (%) (2012-2017)
6 United States Measles Vaccine Market Analysis by Applications
6.1 United States Measles Vaccine Sales (K Sets) and Market Share (%) by Applications (2012-2017)
6.2 United States Measles Vaccine Sales Growth Rate (%) by Applications (2012-2017)
6.3 Pediatric Vaccines Sales Growth Rate
6.4 Adult Vaccines Sales Growth Rate
7 United States Measles Vaccine Players Profiles/Analysis
7.1 Bavarian Nordic
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Measles Vaccine Product Category, End Uses and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Bavarian Nordic Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set), Gross Margin (%) and Market Share (%) (2012-2017)
7.1.4 Main Business/Business Overview
7.2 Emergent Biosolutions
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Measles Vaccine Product Category, End Uses and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Emergent Biosolutions Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set), Gross Margin (%) and Market Share (%) (2012-2017)
7.2.4 Main Business/Business Overview
7.3 GlaxoSmithKline
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Measles Vaccine Product Category, End Uses and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 GlaxoSmithKline Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set), Gross Margin (%) and Market Share (%) (2012-2017)
7.3.4 Main Business/Business Overview
7.4 Medimmune
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Measles Vaccine Product Category, End Uses and Specification
7.4.2.1 Product A
7.4.2.2 Product A
7.4.3 Medimmune Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set), Gross Margin (%) and Market Share (%) (2012-2017)
7.4.4 Main Business/Business Overview
7.5 Johnson & Johnson
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Measles Vaccine Product Category, End Uses and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Johnson & Johnson Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set), Gross Margin (%) and Market Share (%) (2012-2017)
7.5.4 Main Business/Business Overview
7.6 CSL Limited
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Measles Vaccine Product Category, End Uses and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 CSL Limited Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set), Gross Margin (%) and Market Share (%) (2012-2017)
7.6.4 Main Business/Business Overview
7.7 Merck & Co.
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Measles Vaccine Product Category, End Uses and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Merck & Co. Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set), Gross Margin (%) and Market Share (%) (2012-2017)
7.7.4 Main Business/Business Overview
7.8 Novartis AG
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Measles Vaccine Product Category, End Uses and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Novartis AG Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set), Gross Margin (%) and Market Share (%) (2012-2017)
7.8.4 Main Business/Business Overview
7.9 Pfizer
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Measles Vaccine Product Category, End Uses and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Pfizer Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set), Gross Margin (%) and Market Share (%) (2012-2017)
7.9.4 Main Business/Business Overview
7.10 Sanofi
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Measles Vaccine Product Category, End Uses and Specification
7.10.2.1 Type A
7.10.2.2 Type B
7.10.3 Sanofi Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set), Gross Margin (%) and Market Share (%) (2012-2017)
7.10.4 Main Business/Business Overview
8 Measles Vaccine Manufacturing Cost, Industrial Chain and Downstream Buyers
8.1 Measles Vaccine Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Measles Vaccine Industrial Chain Analysis
8.4 Downstream Buyers in United States
9 Marketing Strategy Analysis, Distributors/Traders and Market Effect Factors
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Distributors in Untied States
9.3 Market Effect Factors Analysis
9.3.1 Economic/Political Environmental Change
9.3.2 Downstream Demand Change
9.3.3 Technology Progress in Related Industry
9.3.4 Substitutes Threat
10 United States and Global Measles Vaccine Market Forecast
10.1 Global Measles Vaccine Sales, Revenue Forecast (2017-2022)
10.1.1 Global Measles Vaccine Sales (K Sets) and Growth Rate (%) Forecast (2017-2022)
10.1.2 Global Measles Vaccine Revenue (Million USD) and Growth Rate (%) Forecast (2017-2022)
10.2 United States Measles Vaccine Market Forecast
10.1.1 United States Measles Vaccine Sales (K Sets) and Growth Rate (%) Forecast (2017-2022)
10.2.2 United States Measles Vaccine Revenue (Million USD) and Growth Rate (%) Forecast (2017-2022)
10.3 Global Measles Vaccine Forecast by Regions
10.3.1 North America Measles Vaccine Sales (K Sets) and Revenue (Million USD) Forecast (2017-2022)
10.3.2 Europe Measles Vaccine Sales (K Sets) and Revenue (Million USD) Forecast (2017-2022)
10.3.3 Asia-Pacific Measles Vaccine Sales (K Sets) and Revenue (Million USD) Forecast (2017-2022)
10.3.4 South America Measles Vaccine Sales (K Sets) and Revenue (Million USD) Forecast (2017-2022)
10.3.5 Middle East and Africa Measles Vaccine Sales (K Sets) and Revenue (Million USD) Forecast (2017-2022)
10.4 United Status Measles Vaccine Sales, Revenue Forecast by Type (2017-2022)
10.5 United Status Measles Vaccine Sales (K Sets) Forecast by Application (2017-2022)
11 Research Findings and Conclusion

List of Tables and Figures

Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Figure Product Picture of Measles Vaccine
Table United States Measles Vaccine Sales (K Sets) and Growth Rate (%) Comparison by Types (Product Category) (2012-2022)
Figure United States Measles Vaccine Sales Market Share (%) by Types (Product Category) in 2016
Figure Product Picture of MMR-II
Table Major Players of MMR-II
Figure Product Picture of Proquad
Table Major Players of Proquad
Table United States Measles Vaccine Sales (K Sets) Comparison by Applications (2012-2022)
Figure United States Measles Vaccine Sales Market Share (%) by Applications in 2016
Figure Pediatric Vaccines Examples
Figure Adult Vaccines Examples
Table Global Measles Vaccine Market Size Comparison and Growth (%) by Regions (2012-2022)
Figure North America Measles Vaccine Revenue (Million USD) and Growth Rate (%) (2012-2022)
Figure Asia-Pacific Measles Vaccine Revenue (Million USD) and Growth Rate (%) (2012-2022)
Figure Europe Measles Vaccine Revenue (Million USD) and Growth Rate (%) (2012-2022)
Figure South America Measles Vaccine Revenue (Million USD) and Growth Rate (%) (2012-2022)
Figure Middle East and Africa Measles Vaccine Revenue (Million USD) and Growth Rate (%) (2012-2022)
Figure Global Measles Vaccine Revenue (Million USD) Status and Outlook (2012-2022)
Figure Global Measles Vaccine Sales (K Sets) Status and Outlook (2012-2022)
Figure United States Measles Vaccine Revenue (Million USD) Status and Outlook (2012-2022)
Figure United States Measles Vaccine Sales (K Sets) Status and Outlook (2012-2022)
Table United States Measles Vaccine Sales (K Sets) of Key Players (2012-2017)
Table United States Measles Vaccine Sales Share (%) by Players (2012-2017)
Figure 2016 United States Measles Vaccine Sales Share (%) by Players
Figure 2017 United States Measles Vaccine Sales Share (%) by Players
Table United States Measles Vaccine Revenue (Million USD) by Players (2012-2017)
Table United States Measles Vaccine Revenue Share (%) by Players (2012-2017)
Table 2016 United States Measles Vaccine Revenue Share (%) by Players
Table 2016 United States Measles Vaccine Revenue Share (%) by Players
Table United States Market Measles Vaccine Average Price (USD/Set) of Key Players (2012-2017)
Figure United States Market Measles Vaccine Average Price (USD/Set) of Key Players in 2016
Table United States Measles Vaccine Top Players Manufacturing Base Distribution and Sales Area
Table United States Measles Vaccine Top Players Product Category
Figure Measles Vaccine Market Share (%) of Top 3 Players
Figure Measles Vaccine Market Share (%) of Top 5 Players
Table Global Measles Vaccine Sales (K Sets) by Regions (2012-2017)
Figure Global Measles Vaccine Sales Market Share (%) by Regions (2012-2017)
Figure Global Measles Vaccine Sales Market Share (%) by Regions (2012-2017)
Figure 2016 Global Measles Vaccine Sales Market Share (%) by Regions
Table Global Measles Vaccine Revenue (Million USD) by Regions (2012-2017)
Table Global Measles Vaccine Revenue Market Share (%) by Regions (2012-2017)
Figure Global Measles Vaccine Revenue Market Share (%) by Regions (2012-2017)
Figure 2016 Global Measles Vaccine Revenue Market Share (%) by Regions
Table Global Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set) and Gross Margin (%) (2012-2017)
Table North America Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set) and Gross Margin (%) (2012-2017)
Table Europe Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set) and Gross Margin (%) (2012-2017)
Table Asia-Pacific Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set) and Gross Margin (%) (2012-2017)
Table South America Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set) and Gross Margin (%) (2012-2017)
Table Middle East and Africa Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set) and Gross Margin (%) (2012-2017)
Table United States Measles Vaccine Sales (K Sets) by Types (2012-2017)
Table United States Measles Vaccine Sales Share (%) by Types (2012-2017)
Figure United States Sales Measles Vaccine Market Share (%) by Types (2012-2017)
Figure United States Sales Measles Vaccine Market Share (%) by Types in 2016
Table United States Measles Vaccine Revenue (Million USD) by Types (2012-2017)
Table United States Measles Vaccine Revenue Share (%) by Types (2012-2017)
Figure United States Measles Vaccine Revenue Share (%)by Types (2012-2017)
Figure 2016 United States Measles Vaccine Revenue Market Share (%) by Types
Table United States Measles Vaccine Price (USD/Set) by Types (2012-2017)
Figure United States MMR-II Sales (K Sets) and Growth Rate (%) (2012-2017)
Figure United States MMR-II Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure United States Proquad Sales (K Sets) and Growth Rate (%) (2012-2017)
Figure United States Proquad Revenue (Million USD) and Growth Rate (%) (2012-2017)
Table United States Measles Vaccine Sales (K Sets) by Applications (2012-2017)
Table United States Measles Vaccine Sales Market Share (%) by Applications (2012-2017)
Figure United States Measles Vaccine Sales Market Share (%) by Applications (2012-2017)
Figure United States Measles Vaccine Sales Market Share (%) by Applications in 2016
Table United States Measles Vaccine Sales Growth Rate (%) by Applications (2012-2017)
Figure United States Measles Vaccine Sales Growth Rate (%) by Applications (2012-2017)
Figure United States Pediatric Vaccines Sales (K Sets) and Growth Rate (%) (2012-2017)
Figure United States Adult Vaccines Sales (K Sets) and Growth Rate (%) (2012-2017)
Figure United States Application 3 Sales (K Sets) and Growth Rate (%) (2012-2017)
Table Bavarian Nordic Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bavarian Nordic Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set), Gross Margin (%) and Market Share (%) (2012-2017)
Figure Bavarian Nordic Measles Vaccine Sales Growth Rate (%) (2012-2017)
Figure Bavarian Nordic Measles Vaccine Sales Market Share (%) in United States (2012-2017)
Figure Bavarian Nordic Measles Vaccine Revenue Market Share (%) in United States (2012-2017)
Table Emergent Biosolutions Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Emergent Biosolutions Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set), Gross Margin (%) and Market Share (%) (2012-2017)
Figure Emergent Biosolutions Measles Vaccine Sales Growth Rate (%) (2012-2017)
Figure Emergent Biosolutions Measles Vaccine Sales Market Share (%) in United States (2012-2017)
Figure Emergent Biosolutions Measles Vaccine Revenue Market Share (%) in United States (2012-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set), Gross Margin (%) and Market Share (%) (2012-2017)
Figure GlaxoSmithKline Measles Vaccine Sales Growth Rate (%) (2012-2017)
Figure GlaxoSmithKline Measles Vaccine Sales Market Share (%) in United States (2012-2017)
Figure GlaxoSmithKline Measles Vaccine Revenue Market Share (%) in United States (2012-2017)
Table Medimmune Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Medimmune Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set), Gross Margin (%) and Market Share (%) (2012-2017)
Figure Medimmune Measles Vaccine Sales Growth Rate (%) (2012-2017)
Figure Medimmune Measles Vaccine Sales Market Share (%) in United States (2012-2017)
Figure Medimmune Measles Vaccine Revenue Market Share (%) in United States (2012-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set), Gross Margin (%) and Market Share (%) (2012-2017)
Figure Johnson & Johnson Measles Vaccine Sales Growth Rate (%) (2012-2017)
Figure Johnson & Johnson Measles Vaccine Sales Market Share (%) in United States (2012-2017)
Figure Johnson & Johnson Measles Vaccine Revenue Market Share (%) in United States (2012-2017)
Table CSL Limited Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table CSL Limited Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set), Gross Margin (%) and Market Share (%) (2012-2017)
Figure CSL Limited Measles Vaccine Sales Growth Rate (%) in United States (2012-2017)
Figure CSL Limited Measles Vaccine Sales Market Share (%) in United States (2012-2017)
Figure CSL Limited Measles Vaccine Revenue Market Share (%) in United States (2012-2017)
Table Merck & Co. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck & Co. Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set), Gross Margin (%) and Market Share (%) (2012-2017)
Figure Merck & Co. Measles Vaccine Sales Growth Rate (%) (2012-2017)
Figure Merck & Co. Measles Vaccine Sales Market Share (%) in United States (2012-2017)
Figure Merck & Co. Measles Vaccine Revenue Market Share (%) in United States (2012-2017)
Table Novartis AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis AG Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set), Gross Margin (%) and Market Share (%) (2012-2017)
Figure Novartis AG Measles Vaccine Sales Growth Rate (%) (2012-2017)
Figure Novartis AG Measles Vaccine Sales Market Share (%) in United States (2012-2017)
Figure Novartis AG Measles Vaccine Revenue Market Share (%) in United States (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set), Gross Margin (%) and Market Share (%) (2012-2017)
Figure Pfizer Measles Vaccine Sales Growth Rate (%) (2012-2017)
Figure Pfizer Measles Vaccine Sales Market Share (%) in United States (2012-2017)
Figure Pfizer Measles Vaccine Revenue Market Share (%) in United States (2012-2017)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Measles Vaccine Sales (K Sets), Revenue (Million USD), Price (USD/Set), Gross Margin (%) and Market Share (%) (2012-2017)
Figure Sanofi Measles Vaccine Sales Growth Rate (%) (2012-2017)
Figure Sanofi Measles Vaccine Sales Market Share (%) in United States (2012-2017)
Figure Sanofi Measles Vaccine Revenue Market Share (%) in United States (2012-2017)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Measles Vaccine
Figure Measles Vaccine Industrial Chain Analysis
Table Major Buyers of Measles Vaccine
Table Distributors/Traders List
Figure Global Measles Vaccine Sales (K Sets) and Growth Rate (%) Forecast (2017-2022)
Figure Global Measles Vaccine Revenue (Million USD) and Growth Rate (%) Forecast (2017-2022)
Figure United States Measles VaccineMeasles Vaccine Sales (K Sets) and Growth Rate (%) Forecast (2017-2022)
Figure United States Measles Vaccine Revenue (Million USD) and Growth Rate (%) Forecast (2017-2022)
Table Global Measles Vaccine Sales (K Sets) Forecast by Regions (2017-2022)
Figure Global Measles Vaccine Sales Market Share (%) Forecast by Regions (2017-2022)
Figure North America Measles Vaccine Sales (K Sets) and Growth Rate (%) Forecast (2017-2022)
Figure North America Measles Vaccine Revenue and Growth Rate (%) Forecast (2017-2022)
Figure Europe Measles Vaccine Sales (K Sets) and Growth Rate (%) Forecast (2017-2022)
Figure Europe Measles Vaccine Revenue and Growth Rate (%) Forecast (2017-2022)
Figure Asia-Pacific Measles Vaccine Sales (K Sets) and Growth Rate (%) Forecast (2017-2022)
Figure Asia-Pacific Measles Vaccine Revenue and Growth Rate (%) Forecast (2017-2022)
Figure South America Measles Vaccine Sales (K Sets) and Growth Rate (%) Forecast (2017-2022)
Figure South America Measles Vaccine Revenue and Growth Rate (%) Forecast (2017-2022)
Figure Middle East and Africa Measles Vaccine Sales (K Sets) and Growth Rate (%) Forecast (2017-2022)
Figure Middle East and Africa Measles Vaccine Revenue and Growth Rate (%) Forecast (2017-2022)
Table United Status Measles Vaccine Sales (Million USD) Forecast by Type (2017-2022)
Figure United Status Measles Vaccine Sales Market Share (%) Forecast by Type (2017-2022)
Table United Status Measles Vaccine Revenue (Million USD) Forecast by Type (2017-2022)
Figure United Status Measles Vaccine Revenue Market Share (%) Forecast by Type (2017-2022)
Table United Status Measles Vaccine Sales (K Sets) Forecast by Application (2017-2022)
Figure United Status Measles Vaccine Sales Forecast by Application (2017-2022)





SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $2922
USD $3922
USD $5944

+1 (704) 266-3234

Have a Question?

Why Us

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Trusted by The Best
    Over 400 of the Fortune 500 buy their research from us.
  • Why Us Customer Support
    24 / 7 phone and email support..
  • Why Us Safe & Secure
    Your payment details are protected by us.